Top

News & Events

Client News

Instinctif Partners > News > Client News

Client News Our News Insights Features

16 January 2020
CLINIGEN_Half Year trading update

15 January 2020
Publication in Cancer Research demonstrates Crescendo Biologics’ Humabody® VH therapeutics outperform conventional antibodies in vivo

14 January 2020
Clinigen signs agreement with Iovance Biotherapeutics to supply Proleukin® (aldesleukin) for use in Tumor Infiltrating Lymphocyte (TIL) Clinical R&D

13 January 2020
Feedback plc licence agreement with Imaging Engineering

09 January 2020
Biofidelity and Agilent complete successful molecular assay study for rapid and accurate detection of key lung cancer mutations

09 January 2020
GHO Capital acquires Ardena, a leading CDMO providing early stage drug development and manufacturing for small-to-mid sized biopharma

09 January 2020
Emergex raises more than US$11 million in a Series A Round to Progress its Pipeline of Set-point Vaccines for Infectious Diseases

08 January 2020
NorthSea Therapeutics Announces US $40 Million Series B Financing to Complete Phase IIb ICONA study in NASH and to Advance Two Additional SEFAs into the Clinic

07 January 2020
Synaffix announces expansion of license agreement with Shanghai Miracogen Inc. to a second ADC candidate

07 January 2020
Polyganics Achieves CE Mark Certification for LIQOSEAL®

06 January 2020
Clinigen and Orphazyme launch an Early Access Program for arimoclomol in patients with Niemann-Pick disease type C

06 January 2020
HOOKIPA’s Gilead Sciences Collaboration for HIV and HBV Therapeutic Vaccines Advancing Towards Clinical Entry

Headquartered in the UK

Working for healthcare and life science companies and organisations globally, across Europe, US, EMEA, Asia, Oceania.

Part of the Instinctif Partners group

Berlin, Brussels, Cologne, Dubai, Dublin, Frankfurt, Johannesburg, London, Munich, Oxford

Memberships & Partners

© 2020 Instinctif Partners – Registered in England & Wales No 1036926 / VAT No 245666930